Elamipretide Triacetate: Handling & Research Use Guidelines

Elamipretide triacetate is a water-soluble, cell-permeable aromatic-cationic tetrapeptide (also known as SS-31 or MTP-131) that selectively concentrates in the inner mitochondrial membrane where it binds cardiolipin and supports mitochondrial structure and bioenergetic function.

Chemical Name

Elamipretide triacetate (SS-31 triacetate; MTP-131 triacetate)

SKU

E1439311

Peptide Sequence

D-Arg-Dmt-Lys-Phe-NH₂ (free base core)

Solubility

Soluble in water and aqueous buffers; prepare stock solutions in sterile water or PBS

Primary Target

Cardiolipin in the inner mitochondrial membrane

Recommended Storage

Store desiccated at −20 °C; protect from light and repeated freeze-thaw cycles

Research Application

Mitochondrial dysfunction, oxidative stress, ischemia-reperfusion injury, heart failure models

Mechanism of Action

Elamipretide triacetate is an aromatic-cationic tetrapeptide that penetrates plasma membranes in a potential-independent manner, enabling it to reach the inner mitochondrial membrane regardless of the mitochondrial membrane potential. Once localized there, the peptide binds selectively to cardiolipin, a phospholipid unique to the inner mitochondrial membrane that is essential for organizing the electron transport chain (ETC) supercomplexes and maintaining cristae morphology.

By stabilizing cardiolipin, Elamipretide supports cytochrome c association with the inner membrane, preserves ETC supercomplex integrity, reduces electron leak, and thereby lowers the generation of reactive oxygen species (ROS). The net effect is improved ATP synthesis efficiency and attenuation of mitochondria-driven oxidative stress — two outcomes of high relevance in models of ischemia-reperfusion injury, heart failure, neurodegenerative disease, and aging-related mitochondrial decline.

Preparation and Handling

Reconstitution: Elamipretide triacetate is freely soluble in water and physiological buffers. For most in vitro applications, dissolve the lyophilized powder in sterile, nuclease-free water or phosphate-buffered saline (PBS, pH 7.4) to prepare a concentrated stock solution (e.g., 1–10 mM). Filter-sterilize through a 0.22 µm membrane if the solution will be used in cell culture.

Aliquoting: To minimize degradation from repeated freeze-thaw cycles, divide the stock solution into single-use aliquots immediately after preparation. Aliquots should be stored at −20 °C and used within a validated timeframe.

Working Concentrations: Typical in vitro working concentrations reported in the literature range from nanomolar to low micromolar levels; however, researchers should optimize concentrations empirically for their specific cell or tissue model. For in vivo studies, dosing parameters should be established based on published protocols and institutional animal-use guidelines.

Compatibility: Avoid prolonged exposure to light, strong oxidizing agents, or extreme pH conditions, as these may compromise peptide integrity. Do not combine with solutions containing high concentrations of organic solvents unless solubility has been confirmed.

Storage and Stability

Long-Term Storage: The lyophilized (dry) form of Elamipretide triacetate should be stored desiccated at −20 °C and protected from light. Under these conditions the solid compound is expected to be stable for at least 2 years from date of manufacture, though researchers should confirm stability with their institutional QC records or the certificate of analysis (CoA) supplied with the product (SKU E1439311).

Reconstituted Solution Stability: Once dissolved, aqueous solutions are more susceptible to degradation. Reconstituted solutions should be used promptly; for short-term storage (up to 1 month), aliquots may be kept at −20 °C. Avoid multiple freeze-thaw cycles. The stability of reconstituted solutions over extended periods has not been fully characterized and should be treated as a review flag pending further validation.

Shipping: The compound is typically shipped on dry ice or with cold packs. Upon receipt, inspect the container for integrity, record the lot number and CoA data, and transfer to appropriate storage immediately.

Research Applications and Experimental Considerations

In Vitro Models: Elamipretide triacetate is widely used in cell-based assays to investigate mitochondrial bioenergetics, ROS production, mitochondrial membrane potential, and apoptotic signaling. Common readouts include oxygen consumption rate (OCR) measured by respirometry (e.g., Seahorse XF), JC-1 or TMRE fluorescence for membrane potential, and MitoSOX staining for mitochondrial superoxide.

In Vivo Models: The compound has been studied in rodent models of cardiac ischemia-reperfusion injury, heart failure with preserved ejection fraction (HFpEF), skeletal muscle aging, and renal ischemia. Route of administration in preclinical studies has typically been subcutaneous injection or intravenous infusion. Researchers should consult primary literature and institutional IACUC protocols when designing in vivo experiments.

Controls and Comparators: Appropriate negative controls (vehicle-treated) and, where applicable, positive controls using established mitochondrial uncouplers (e.g., FCCP) or antioxidants should be included. Scrambled peptide or inactive analogues, if available, can serve as structural controls.

Note on Salt Form: Elamipretide is supplied here as the triacetate salt (SKU E1439311). When comparing doses or concentrations across studies using different salt forms (free base, hydrochloride, or triacetate), researchers must account for differences in molecular weight to ensure molar equivalence.

Quality, Purity and Regulatory Notes

Purity: Elamipretide triacetate (SKU E1439311) is supplied as a research-grade reagent. Researchers should consult the Certificate of Analysis (CoA) provided with each lot for confirmed purity data, typically assessed by HPLC, and identity confirmation by mass spectrometry. The CoA lot number should be recorded in laboratory notebooks for traceability.

Research Use Only: This product is intended strictly for laboratory research purposes. It is not approved, certified, or intended for use in diagnostic procedures, human therapeutic applications, or veterinary clinical use without appropriate regulatory authorization.

Safety Handling: While Elamipretide is a peptide of relatively low acute toxicity, standard laboratory safety practices apply: wear appropriate PPE (gloves, lab coat, eye protection), avoid inhalation of lyophilized powder, and dispose of waste in accordance with institutional and local regulations. Refer to the Safety Data Sheet (SDS) for comprehensive hazard information.

Frequently asked questions

What is the difference between Elamipretide triacetate and Elamipretide hydrochloride?

Both are salt forms of the same active tetrapeptide (SS-31). The difference lies in the counterion — acetate versus chloride — which affects the molecular weight and therefore the mass required to achieve equivalent molar concentrations. When designing experiments or comparing results across studies, researchers must use the correct molecular weight for the salt form in use (SKU E1439311 is the triacetate salt) to calculate accurate molar doses.

How should I prepare a stock solution of Elamipretide triacetate?

Dissolve the lyophilized powder in sterile, nuclease-free water or PBS (pH 7.4) to the desired concentration (commonly 1–10 mM). Vortex gently until fully dissolved, then filter-sterilize through a 0.22 µm membrane if the solution will be used in cell culture. Divide immediately into single-use aliquots and store at −20 °C to avoid repeated freeze-thaw cycles.

What assays are most appropriate for measuring Elamipretide's effect on mitochondrial function in vitro?

The most informative assays include: (1) Seahorse XF respirometry to measure oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), capturing changes in oxidative phosphorylation and glycolysis; (2) JC-1 or TMRE fluorescence assays to assess mitochondrial membrane potential; and (3) MitoSOX Red staining for mitochondrial superoxide detection. ATP quantification assays and cytochrome c release assays may also be valuable depending on the experimental question.

Is Elamipretide triacetate suitable for in vivo administration?

Elamipretide has been used in various preclinical animal models, most commonly via subcutaneous injection or intravenous infusion. However, dosing regimens, vehicle selection, and administration routes must be carefully validated for each specific animal model and experimental endpoint. Researchers should consult published literature and obtain appropriate institutional (IACUC) approvals before proceeding with in vivo studies. Note that SKU E1439311 is supplied as a research-grade reagent and is not formulated for clinical or veterinary therapeutic use.

References

1. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171(8):2029-2050. doi:10.1111/bph.12461
2. Birk AV, Liu S, Soong Y, et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol. 2013;24(8):1250-1261. doi:10.1681/ASN.2012121216
3. Daubert MA, Yow E, Dunn G, et al. Novel mitochondria-targeting peptide in heart failure treatment: a randomized, placebo-controlled trial of elamipretide. Circ Heart Fail. 2017;10(12):e004389. doi:10.1161/CIRCHEARTFAILURE.117.004389
4. Zhao K, Zhao GM, Wu D, et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem. 2004;279(33):34682-34690. doi:10.1074/jbc.M402999200

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.